Vanguard Group Inc Ensysce Biosciences, Inc. Transaction History

Vanguard Group Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.05 - $153.6 $9,673 - $29.7 Million	193,475 Added 158.13%	315,828 $68,000
Q1 2022 May 13, 2022	SELL	$230.4 - $1140.0 $41.2 Million - $204 Million	-178,946 Reduced 59.39%	122,353 $140,000
Q4 2021 Feb 14, 2022	BUY	$300.0 - $1228.8 $90.4 Million - $370 Million	301,299 New	301,299 $1.42 Million

100

Ticker ENSC
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,918,900
Market Cap $12.8M
Description
Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection platform, an abuse-resistant opioid prodrug technology; and Multi-Pill Abu...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.